Study of blood clots in hearts with amyloidosis
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how often blood clots form in the hearts of people with cardiac amyloidosis (a disease where abnormal proteins build up in heart tissue). Understanding clot risk may help doctors better protect patients from stroke and other complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed diagnosis of cardiac amyloidosis (either AL type with biopsy proof, or ATTR type with typical heart imaging findings)
- Seen at Dijon University Hospital for your cardiac amyloidosis within the past year
- Age 18 or older
- Kidneys working well enough (eGFR at least 30)
- No previous blood clots in your heart
- No allergy to iodine-based contrast dye used in imaging
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of imaging scan ([64Cu]FBP8 PET) to detect blood clots that may form in the heart's left atrial appendage (a small pouch in the heart) in patients with amyloid cardiomyopathy (a disease where abnormal protein builds up in heart muscle) who also have irregular heartbeat. The scan may help doctors catch clots earlier and prevent strokes.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
This study looks at how cardiac amyloidosis shows up on heart imaging, especially ultrasound (echocardiography). It may help doctors better describe and track the condition using your exam and test results.
This study looks at past bone scans to find signs of a heart condition called amyloidosis, where abnormal proteins build up in the heart. It may help identify more people with this condition and improve future diagnosis.
This study uses special heart tests (AI-ECG and CT scan) to look for a hidden condition called cardiac amyloidosis, which can affect people with atrial fibrillation. Finding it early may help guide treatment and improve outcomes.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.